77 related articles for article (PubMed ID: 8992989)
1. The hinge as a spacer contributes to covalent assembly and is required for function of IgG.
Coloma MJ; Trinh KR; Wims LA; Morrison SL
J Immunol; 1997 Jan; 158(2):733-40. PubMed ID: 8992989
[TBL] [Abstract][Full Text] [Related]
2. Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.
Smith RI; Coloma MJ; Morrison SL
J Immunol; 1995 Mar; 154(5):2226-36. PubMed ID: 7868896
[TBL] [Abstract][Full Text] [Related]
3. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
[TBL] [Abstract][Full Text] [Related]
4. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity.
Gavin AL; Barnes N; Dijstelbloem HM; Hogarth PM
J Immunol; 1998 Jan; 160(1):20-3. PubMed ID: 9551950
[TBL] [Abstract][Full Text] [Related]
5. Activation of complement by an IgG molecule without a genetic hinge.
Brekke OH; Michaelsen TE; Sandin R; Sandlie I
Nature; 1993 Jun; 363(6430):628-30. PubMed ID: 8510754
[TBL] [Abstract][Full Text] [Related]
6. Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge.
Norderhaug L; Brekke OH; Bremnes B; Sandin R; Aase A; Michaelsen TE; Sandlie I
Eur J Immunol; 1991 Oct; 21(10):2379-84. PubMed ID: 1915551
[TBL] [Abstract][Full Text] [Related]
7. Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgG.
Sørensen V; Rasmussen IB; Norderhaug L; Natvig I; Michaelsen TE; Sandlie I
J Immunol; 1996 Apr; 156(8):2858-65. PubMed ID: 8609405
[TBL] [Abstract][Full Text] [Related]
8. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
9. Structural difference in the complement activation site of human IgG1 and IgG3.
Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
[TBL] [Abstract][Full Text] [Related]
10. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly.
Atkin JD; Pleass RJ; Owens RJ; Woof JM
J Immunol; 1996 Jul; 157(1):156-9. PubMed ID: 8683109
[TBL] [Abstract][Full Text] [Related]
12. A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells.
Michaelsen TE; Thommesen JE; Ihle O; Gregers TF; Sandin RH; Brekke OH; Sandlie I
Eur J Immunol; 2006 Jan; 36(1):129-38. PubMed ID: 16323243
[TBL] [Abstract][Full Text] [Related]
13. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins.
Tan LK; Shopes RJ; Oi VT; Morrison SL
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):162-6. PubMed ID: 2296577
[TBL] [Abstract][Full Text] [Related]
14. A genetically engineered human IgG mutant with enhanced cytolytic activity.
Shopes B
J Immunol; 1992 May; 148(9):2918-22. PubMed ID: 1573276
[TBL] [Abstract][Full Text] [Related]
15. The influence of the hinge region length in binding of human IgG to human Fcgamma receptors.
Redpath S; Michaelsen TE; Sandlie I; Clark MR
Hum Immunol; 1998 Nov; 59(11):720-7. PubMed ID: 9796740
[TBL] [Abstract][Full Text] [Related]
16. Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced.
Berasain P; Carmona C; Frangione B; Dalton JP; Goñi F
Exp Parasitol; 2000 Feb; 94(2):99-110. PubMed ID: 10673346
[TBL] [Abstract][Full Text] [Related]
17. One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.
Michaelsen TE; Brekke OH; Aase A; Sandin RH; Bremnes B; Sandlie I
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9243-7. PubMed ID: 7937748
[TBL] [Abstract][Full Text] [Related]
18. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1.
Medesan C; Matesoi D; Radu C; Ghetie V; Ward ES
J Immunol; 1997 Mar; 158(5):2211-7. PubMed ID: 9036967
[TBL] [Abstract][Full Text] [Related]
19. From IgG monoclonals to IgM-like molecules.
Ernst M; Meier D; Sonneborn HH
Hum Antibodies; 1999; 9(3):165-70. PubMed ID: 10690630
[TBL] [Abstract][Full Text] [Related]
20. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]